Literature DB >> 25299103

Association of the rs7903146 and rs12255372 polymorphisms in the TCF7L2 gene with type 2 diabetes in a population from northeastern Brazil.

C M A R Barros1, A P Araujo-Neto1, T R Lopes1, M A L Barros1, F J N Motta1, R Canalle1, L C C Nunes2, J A Rey3, R R Burbano4, M A Lima-Barros5, F K N Yoshioka1, G R Pinto6.   

Abstract

Approximately 200 million people suffer from type 2 diabetes (T2D) worldwide, and the rapid increase in the prevalence of this disease is likely a result of multiple environmental factors, such as increased food intake and decreased physical activity in genetically predisposed individuals. Different population studies have demonstrated a strong association of two polymorphic variations in the TCF7L2 gene, the noncoding single nucleotide polymorphisms (SNPs) rs7903146 (C/T) and rs12255372 (G/T), with T2D. Herein, we analyzed the association of these SNPs with T2D in a population from northeastern Brazil. Our results showed that the genotype and allele frequencies in TCF7L2 rs7903146 and rs12255372 were similar in the patient and control groups (P > 0.05). In addition, the allele frequencies were not significantly associated with T2D risk [rs7903146: odds ratio (OR) = 0.95, 95% confidence interval (CI) = 0.52-1.76, P = 1.00, and rs12255372: OR = 1.38, 95%CI = 0.72-2.62, P = 0.41]. These data suggest that the TCF7L2 SNPs rs7903146 and rs12255372 may not significantly contribute to T2D susceptibility in this population. However, our results may reflect the small number of subjects. Alternatively, these results may be attributable to specific ethnic effects, as most of the previously reported associations were demonstrated with predominantly European populations. To reach a definitive conclusion on the role of such gene variants for T2D in mixed populations, additional efforts are necessary to replicate this study with larger populations from areas with more ethnic heterogeneity.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25299103     DOI: 10.4238/2014.September.29.1

Source DB:  PubMed          Journal:  Genet Mol Res        ISSN: 1676-5680


  5 in total

Review 1.  Genetic markers predicting sulphonylurea treatment outcomes in type 2 diabetes patients: current evidence and challenges for clinical implementation.

Authors:  N K Loganadan; H Z Huri; S R Vethakkan; Z Hussein
Journal:  Pharmacogenomics J       Date:  2016-01-26       Impact factor: 3.550

2.  Increased seroreactivity to proinsulin and homologous mycobacterial peptides in latent autoimmune diabetes in adults.

Authors:  Magdalena Niegowska; Alessandro Delitala; Giovanni Mario Pes; Giuseppe Delitala; Leonardo A Sechi
Journal:  PLoS One       Date:  2017-05-04       Impact factor: 3.240

3.  Targeted deletion of Tcf7l2 in adipocytes promotes adipocyte hypertrophy and impaired glucose metabolism.

Authors:  Gisela Geoghegan; Judith Simcox; Marcus M Seldin; Timothy J Parnell; Chris Stubben; Steven Just; Lori Begaye; Aldons J Lusis; Claudio J Villanueva
Journal:  Mol Metab       Date:  2019-03-14       Impact factor: 7.422

4.  Associations of transcription factor 7-Like 2 (TCF7L2) gene polymorphism in patients of type 2 diabetes mellitus from Khyber Pakhtunkhwa population of Pakistan.

Authors:  Taha Hameed; Zahid Khan; Muhammad Imran; Saif Ali; Abdullah Abdo Albegali; Muhammad Ikram Ullah; Hasan Ejaz
Journal:  Afr Health Sci       Date:  2021-03       Impact factor: 0.927

5.  Significant Association of Polymorphisms in the TCF7L2 Gene with a Higher Risk of Type 2 Diabetes in a Moroccan Population.

Authors:  Sarah Elhourch; Housna Arrouchi; Nour Mekkaoui; Younes Allou; Fatima Ghrifi; Loubna Allam; Naima Elhafidi; Lahcen Belyamani; Azeddine Ibrahimi; Naoual Elomri; Rachid Eljaoudi
Journal:  J Pers Med       Date:  2021-05-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.